SCHEMBL5773072

SCHEMBL5773072

Oc1cccc(-c2cc3nccc(N4CCCCC4)c3[nH]2)c1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CCNB2 O95067 1/20 0.52
CDK1 P06493 1/20 0.52
CCNB1 P14635 1/20 0.52
CCNB3 Q8WWL7 1/20 0.52
NPY5R Q15761 16/20 0.50
ADORA3 P0DMS8 1/20 0.44
ADORA2A P29274 1/20 0.44
ADORA2B P29275 1/20 0.44
ADORA1 P30542 1/20 0.44
PIK3CA P42336 1/20 0.44
PIK3CG P48736 1/20 0.44
RIPK1 Q13546 1/20 0.42
KDM4A O75164 1/20 0.41
KDM5A P29375 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
KDM5B Q9UGL1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5771574 0.86 NPY5R (0.65) NPY5RKDM4AKDM5AKDM4CKDM5B
Hydrochloric Acid SCHEMBL5776809 0.85 NPY5R (0.64) NPY5RKDM4AKDM5AKDM4CKDM5B
SCHEMBL5777964 0.79 NPY5R (0.57) CCNB2CDK1CCNB1CCNB3NPY5R
SCHEMBL5774219 0.77 NPY5R (0.61) CCNB2CDK1CCNB1CCNB3NPY5R
SCHEMBL5777347 0.74 NPY5R (0.77) NPY5R
Hydrochloric Acid SCHEMBL5796851 0.73 NPY5R (0.73) NPY5R
SCHEMBL5776649 0.72 NPY5R (0.40) NPY5RKDM5AKDM4CKDM5B
Hydrochloric Acid SCHEMBL5776805 0.71 PSMB5 (0.41) NPY5RKDM5AKDM4CKDM5B
SCHEMBL5771571 0.69 KDM5A (0.55) NPY5RKDM5AKDM4CKDM5B
Bromide SCHEMBL490969 0.68 CCNB2 (0.97) CCNB2CDK1CCNB1CCNB3RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP claimed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US claimed
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed